Core Viewpoint - Treace Medical Concepts, Inc. has filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. for patent infringement related to its Lapiplasty® 3D Bunion Correction® technologies, seeking injunctive relief and damages [1]. Group 1: Company Overview - Treace Medical Concepts is a medical technology company focused on advancing surgical treatment for bunions and midfoot deformities, with an estimated 67 million Americans affected by bunions, of which 1.1 million are annual surgical candidates [3]. - The company has developed and patented the Lapiplasty® 3D Bunion Correction® System, which addresses the root cause of bunions by correcting deformities in three planes and stabilizing the affected joint [3]. - Treace's patent portfolio includes 80 granted U.S. patents and 26 granted patents worldwide, along with over 150 pending patent applications, highlighting its commitment to innovation and intellectual property protection [2]. Group 2: Legal Action - The lawsuit filed by Treace aims to protect its significant investments in research and technology, emphasizing the importance of enforcing intellectual property rights to foster continued innovation [2]. - The legal action is seen as a necessary step to safeguard the company's pioneering position in the surgical treatment of bunions [2].

Treace Medical Concepts (TMCI) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Philip Taylor - PrincipalJohn Treace - CEO, Founder & ChairmanMark Hair - Chief Financial OfficerIseult McMahon - Equity Research AssociateFelipe Lamar - Senior Equity Research AssociateJayna Francis - Equity Research Associate Conference Call Participants Lilia-Celine Lozada - Analyst Operator Good day, and thank you for standing by. Welcome to the Therese Medical Concepts first quarter twenty twenty five ear ...

Treace Medical Concepts (TMCI) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the Therese Medical Concepts first quarter twenty twenty five earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising that your hand h ...

PONTE VEDRA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Generated revenue of $52.6 million in first quarter 2025 representing growth of 3% over the same pe ...

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations, Gilmartin Group John Treace - Chief Executive Officer Mark Hair - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Lily Lozada - JPMorgan Kallum Titchmarsh - Morgan Stanley Richard Newitter - Truist Securities Danielle Antalffy - UBS Ben Haynor - Lake Street Capital Markets Operator Welcome to the Treace Medical Concep ...